Regeneron Pharma (REGN) PT Raised to $895 at Piper Sandler
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $797.99 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 9 | New: 6
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 9 | New: 6
Join SI Premium – FREE
Piper Sandler analyst Christopher Raymond raised the price target on Regeneron Pharma (NASDAQ: REGN) to $895.00 (from $885.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Avino Silver & Gold (ASM) PT Raised to $10.50 at H.C. Wainwright
- Progyny (PGNY) PT Raised to $36 at Truist Securities
- Definium Therapeutics Inc (DFTX) PT Raised to $64 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
